Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Laureate Education Inc is an education & training services business based in the US. Laureate Education shares (LAUR) are listed on the NASDAQ and all prices are listed in US Dollars. Laureate Education employs 14,000 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
| Latest market close | $11.72 |
|---|---|
| 52-week range | $7.97 - $13.35 |
| 50-day moving average | $11.89 |
| 200-day moving average | $12.67 |
| Wall St. target price | $14.83 |
| PE ratio | 6.7353 |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $1.70 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $11.72 from 2022-07-01
| 1 week (2022-06-24) | 3.26% |
|---|---|
| 1 month (2022-06-02) | -10.81% |
| 3 months (2022-03-31) | -1.10% |
| 6 months (2021-12-31) | -4.25% |
| 1 year (2021-07-02) | -20.76% |
|---|---|
| 2 years (2020-07-02) | 15.47% |
| 3 years (2019-07-02) | 15.84 |
| 5 years (2017-06-30) | 17.53 |
Valuing Laureate Education stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Laureate Education's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Laureate Education's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 7x. In other words, Laureate Education shares trade at around 7x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Laureate Education's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.1465. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Laureate Education's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Laureate Education's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $260.6 million.
The EBITDA is a measure of a Laureate Education's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $1.1 billion |
|---|---|
| Operating margin TTM | 15.23% |
| Gross profit TTM | $477.2 million |
| Return on assets TTM | 3.13% |
| Return on equity TTM | -11.15% |
| Profit margin | 28.43% |
| Book value | $6.07 |
| Market capitalisation | $2 billion |
TTM: trailing 12 months
Dividend payout ratio: 4.49% of net profits
Recently Laureate Education has paid out, on average, around 4.49% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Laureate Education shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In Laureate Education's case, that would currently equate to about $0 per share.
While Laureate Education's payout ratio might seem low, this can signify that Laureate Education is investing more in its future growth.
Laureate Education's most recent dividend payout was on 27 December 2021. The latest dividend was paid out to all shareholders who bought their shares by 12 December 2021 (the "ex-dividend date").
Over the last 12 months, Laureate Education's shares have ranged in value from as little as $7.9738 up to $13.35. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Laureate Education's is 0.8403. This would suggest that Laureate Education's shares are less volatile than average (for this exchange).
Laureate Education, Inc. , together with its subsidiaries, provides higher education programs and services to students through a network of universities and higher education institutions. The company offers a range of undergraduate and graduate degree programs in the areas of business and management, medicine and health sciences, and engineering and information technology through campus-based, online, and hybrid programs. It provides its services in Mexico, Peru, and the United States. The company was formerly known as Sylvan Learning Systems, Inc. and changed its name to Laureate Education, Inc. in May 2004.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Everything we know about the Warrantee IPO, plus information on how to buy in.
Everything we know about the Treasure Global IPO, plus information on how to buy in.
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.